Key result
Higher RC/HDL-C ratio is linked to ~6-fold higher MAFLD risk.
Why the study?
Is the remnant cholesterol to high-density lipoprotein cholesterol (RC/HDL-C) ratio associated with the risk of metabolic-associated fatty liver disease (MAFLD)?
Cross-Sectional (n=2,589)
Is the remnant cholesterol to high-density lipoprotein cholesterol (RC/HDL-C) ratio associated with the risk of metabolic-associated fatty liver disease (MAFLD)?
Odds Ratio: 5.91 (95% CI 4.06–8.74)
p-value: p=< 0.001
The RC/HDL-C ratio has a significant nonlinear positive relationship with MAFLD and may serve as a potential risk-related biomarker.
This study aimed to explore the association between the ratio of remnant cholesterol to high-density lipoprotein cholesterol (RC/HDL-C) and metabolic-associated fatty liver disease (MAFLD). This cross-sectional study included 2,589 participants underwent physical examinations from 2015 to 2017. Logistic regression, restricted cubic spline (RCS), subgroup analysis and receiver operating characteristic (ROC) curve analysis were applied to assess the association between RC/HDL-C ratio and the risk of MAFLD. There is a positive correlation between RC/HDL-C ratio and the risk of MAFLD (P for trend < 0.001). Results from the multivariate logistic regression analysis showed a positive association between RC/HDL-C ratio and MAFLD (Q4 vs. Q1: OR = 5.91, 95%CI: 4.06–8.74). The results remain stable in subgroup analyses. RCS analysis showed a significant non-linear dose-response relationship (P for nonlinear < 0.001) between RC/HDL-C ratio and the risk of MAFLD. ROC analysis indicated that RC/HDL-C had modest discriminative ability for MAFLD (AUC = 0.778, 95%CI: 0.758–0.797). This cross-sectional study found a significant nonlinear positive relationship between RC/HDL-C and MAFLD, and RC/HDL-C showed modest discriminative ability for MAFLD. These findings suggest that RC/HDL-C may serve as a potential risk-related biomarker for MAFLD.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cross-sectional in Metabolic-associated fatty liver disease (MAFLD) (n=2,589). Remnant cholesterol/high-density lipoprotein cholesterol (RC/HDL-C) ratio vs. Lowest quartile (Q1) was evaluated on Metabolic-associated fatty liver disease (MAFLD) (OR 5.91, 95% CI 4.06-8.74, p=< 0.001). A higher RC/HDL-C ratio was significantly associated with an increased risk of MAFLD (Q4 vs. Q1: OR 5.91; 95% CI 4.06-8.74), demonstrating a significant nonlinear dose-response relationship.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: